For example: Apple Inc, UTIL, Aluminum
Corbus Pharmaceuticals Hldgs Inc
NASDAQ:CRBP
Market Close 11/27
1.22 USD +0.02 (+1.67%)
OPEN:
1.22
DAY RANGE:
1.18 - 1.22
PE:
-7.14
PB:
12.15
PS:
13.16
WTD % 0.83
MTD % 29.83
QTD % -32.22
YTD % -77.66
* Updated at market close
Corbus Pharmaceuticals Hldgs Inc (NASDAQ:CRBP) opened on Nov 27, 2020 at 1.22 USD and increased by 1.67%. The intraday price range was 1.18 - 1.22 USD and eventually ended the session at 1.22 USD. The stock trade volume was 2.12 M shares. The company's 52-week range is 0.91 - 9.78 USD.
Trading Statistics (Market Close Nov 27, 2020)
Market Cap 99.69 M
Outstanding Stock 57.24 M
Dividend 0.00
Dividend Yield 0.00
EPS -0.97
YTD Change -77.66%
52 Week's Range 0.91 - 9.78
Key Ratio & Margins (Market Close Nov 27, 2020)
Price/Earning -7.14
Price/Book Value 12.15
Price/Sales 13.16
ROA -
ROE -
Debt/Equity 0.78
Company Self Description
Corbus Pharmaceuticals Holdings, Inc.focuses on the development and commercialization of various therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. It was founded in 2009 and is based in Norwood, Massachusetts, United States.
Business Information
Corbus Pharmaceuticals Hldgs Inc
Sector Health Care
Industry Biotechnology
Exchange NASDAQ
Top Competitors (Market Close Nov 27, 2020)
  CRBP CDTX CELC LMNL
Daily Change (%) 1.67 1.30 5.78 4.28
WTD (%) 0.83 -3.72 12.26 -14.81
MTD (%) 29.83 -10.73 72.30 -10.00
QTD (%) -32.22 -18.25 70.52 -62.80
YTD (%) -77.66 -39.32 -7.05 -50.60
52-Week Change (%) -73.48 1.30 -2.56 -28.57
Stock Performance (Market Close Nov 27, 2020)
  CRBP CDTX CELC LMNL
Daily Change (%) 1.67 1.30 5.78 4.28
WTD (%) 0.83 -3.72 12.26 -14.81
MTD (%) 29.83 -10.73 72.30 -10.00
QTD (%) -32.22 -18.25 70.52 -62.80
YTD (%) -77.66 -39.32 -7.05 -50.60
52-Week Change (%) -73.48 1.30 -2.56 -28.57
Key Fundamentals (Market Close Nov 27, 2020)
  CRBP CDTX CELC LMNL
Market Cap 99.69 M 100.09 M 101.76 M 99.36 M
Revenue Growth - - - -
Net Income Growth - - - -
Profit Margin -164.70% 0.00 0.00 0.00
P/E Ratio -7.14 -0.84 -35.21 -35.21
Price to Sales Ratio 13.16 0 0 0
Price to Book Ratio 12.15 1.10 9.61 9.61
Enterprise Value to EBITDA -5.05 0.15 -33.06 -33.06
ROA - -77.90% -28.40% -28.40%
ROE - -109.60% -29.50% -29.50%
Debt/Equity 0.78 0.34 0.03 0.03
Asset Turnover Ratio 0.46 0 0 0
Current Ratio 2.45 3.88 38.08 38.08
Dividend Yield 0.00 0 0 0
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Revenue 4.82 M 2.44 M 1.91 M 648,382.00
Cost Of Revenue 0.00 0.00 0.00 0.00
Gross Profit 4.82 M 2.44 M 1.91 M 648,382.00
Selling General & Administrative Expenses 12.96 M 8.96 M 6.46 M 3.61 M
Research & Development 48.61 M 26.04 M 15.44 M 5.89 M
Operating Income -56.75 M -32.56 M -19.99 M -8.85 M
Net Income -55.67 M -32.42 M -20.00 M -8.85 M
EPS -0.98 -0.65 -0.49 -0.28
Diluted EPS -0.98 -0.65 -0.49 -0.28
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Revenue 29.09 M 1.89 M 1.93 M 1.09 M
Cost Of Revenue 0.00 0.00 0.00 0.00
Gross Profit 29.09 M 1.89 M 1.93 M 1.09 M
Selling General & Administrative Expenses 5.21 M 6.62 M 3.74 M 3.18 M
Research & Development 22.18 M 21.78 M 15.78 M 12.81 M
Operating Income 1.71 M -26.52 M -17.59 M -14.90 M
Net Income 2.15 M -26.23 M -17.31 M -14.60 M
EPS 0.03 -0.43 -0.31 -0.26
Diluted EPS 0.03 -0.43 -0.31 -0.26
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Total Current Assets 44.24 M 65.50 M 17.40 M 12.71 M
Cash & Cash Equivalents 41.75 M 62.70 M 15.19 M 12.37 M
Total Assets 46.99 M 66.98 M 17.89 M 12.88 M
Total Current Liabilities 18.09 M 8.20 M 8.90 M 3.63 M
Total Liabilities 19.47 M 9.19 M 8.97 M 3.89 M
Shareholder's Equity 27.52 M 57.78 M 8.92 M 8.99 M
Outstanding Stock 57.24 M 54.87 M 44.44 M 37.61 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Total Current Assets 75.39 M 92.82 M 44.24 M 58.46 M
Cash & Cash Equivalents 73.15 M 89.92 M 41.75 M 55.66 M
Total Assets 84.12 M 101.39 M 46.99 M 61.18 M
Total Current Liabilities 29.44 M 52.04 M 18.09 M 16.93 M
Total Liabilities 36.75 M 59.09 M 19.47 M 18.31 M
Shareholder's Equity 47.37 M 42.30 M 27.52 M 42.87 M
Outstanding Stock 64.46 M 64.40 M 57.24 M 57.21 M
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net Cash Flow from Operations -30.07 M -27.80 M -13.57 M -4.62 M
Capital Expenditures -2.30 M -707,429.00 -353,032.00 -114,037.00
Net Cash Flow from Investing Activities -2.30 M -707,429.00 -353,032.00 -114,037.00
Net Cash Flow from Financial Activities 11.42 M 76.01 M 16.74 M 10.84 M
Free Cash Flow -32.37 M -28.50 M -13.92 M -4.74 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Net Cash Flow from Operations -16.39 M -27.80 M -13.57 M -4.62 M
Capital Expenditures -183,283.00 -73,615.00 -249,754.00 -105,797.00
Net Cash Flow from Investing Activities -183,283.00 -73,615.00 -249,754.00 -105,797.00
Net Cash Flow from Financial Activities -191,170.00 37.93 M 403,200.00 -64,416.00
Free Cash Flow -16.57 M 10.24 M -14.31 M -8.95 M
Key Ratios (Market Close Nov 27, 2020)
Valuation Ratios 2020 2019 2018 2017
P/E Ratio -7.14 -5.74 -5.96 -8.48
Price to Sales Ratio 13.16 74.45 69.03 149.23
Price to Book Ratio 12.15 6.74 42.10 6.91
Enterprise Value to EBIT -5.00 -11.00 -18.00 -6.00
Enterprise Value to EBITDA -5.05 -10.97 -17.90 -5.55
Profitability Ratios 2020 2019 2018 2017
Revenue Growth - - - -
Net Income Growth - - - -
ROA - - -87.10% -64.70%
ROE - - -116.30% -75.90%
Liquidity Ratios 2020 2019 2018 2017
Working Capital 26.15 M 57.30 M 8.50 M 9.08 M
Current Ratio 2.45 7.98 1.96 3.50
Efficiency & Capital Structure Ratios 2020 2019 2018 2017
Debt Equity Ratio 0.78 0.16 1.01 0.43
Asset Turnover Ratio - - 0.08 0.05
Scratchpad (max of 30 tickers)
Symbol Last Price Change
Empty Scratchpad
Portfolio (max of 30 tickers)
Login is required to view your portfolio.